http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-416024-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd93bb1b16087383c339db5f119a5094
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-26
filingDate 2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42b1cddadac8b683ac912c97e256d8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7610168cfc3ed7cf9c89b6d39154288
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0001e31d84cdad56a1fb3197b453ab52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9a4540a9ba7a03194c9516d92af8138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0fbc4339c0b40b35b1e535ed0931718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65348c750d3f46ef9468d81ce7bdfa27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165364e35c7337bcabfe70d7b44a9d8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d83c68cf3ea6f60f89453ff7f74a6fb5
publicationDate 2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-416024-A1
titleOfInvention Method for the preparation of mono-substituted 2,7-dihydro-3H-dibenzo [de, h] cinnoline-3,7-dione derivatives
abstract The subject of the application is a process for the preparation of mono-substituted antrapiridazone derivatives of formula (I), wherein R1 is - (CH2) q-N (R4) -R5, where q = 2 or 3; R4 and R5 are the same and represent C1-C3-alkyl, or R4 and R5 together with the nitrogen atom in the 2-position to which they are attached form a 6-membered cyclic ring optionally containing an additional nitrogen or oxygen atom, such as a piperazine ring, piperidine or morpholine. The method consists in the fact that 6-chloro-2,7-dihydro-3H-dibenzo [de, h] cinnoline-3,7-dione is subjected to an N-alkylation reaction with an alkylaminoalkyl chloride of formula Cl- (CH2) qN (R4) -R5, in which q, R4 and R5 have the same meaning as in formula (I), or a salt thereof, in the presence of an acid binding agent, preferably potassium carbonate.
priorityDate 2016-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448020525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420943373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID686386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11430
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21179883
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416059909

Total number of triples: 30.